November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Alessio Cortellini: Immune-suppressive role of RANKL in patients with NSCLC treated with ICI
Jun 29, 2024, 14:51

Alessio Cortellini: Immune-suppressive role of RANKL in patients with NSCLC treated with ICI

Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post by Journal for ImmunoTherapy of Cancer, on X:

Happy to share this work out on Journal for ImmunoTherapy of Cancer on the potential immune-suppressive role of RANKL in patients with NSCLC treated with ICI. Entirely thought through and performed at UCBM.”.

Quoting Journal for ImmunoTherapy of Cancer‘s post:

New JITC article: Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC).

Alessio Cortellini: Immune-suppressive role of RANKL in patients with NSCLC treated with ICI

Read further.
Source: Alessio Cortellini/X and Journal for ImmunoTherapy of Cancer/X